Operator
Welcome to the Q1 2021 Intercept Pharmaceuticals Earnings Call. My name is Anette, and I ll be your operator for today s call. [Operator Instructions]
I will now turn the call over to Lisa DeFrancesco. Lisa, you may begin.
Lisa DeFrancesco
Senior Vice President of Investor Relations and Corporate Affairs
Thank you. Good morning, and thank you for joining us on today s call. This morning, we issued a press release announcing our first quarter 2021 results and financial position, which is available on our website at www.interceptpharma.com. Before we begin our discussion, I d like to note that during our call, we will be making forward-looking statements, including statements regarding our approved product and clinical development program; certain regulatory matters; and our strategy, prospects, financial guidance and future commercial and financial performance. Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as
XP POWER LTD - Result of Annual General Meeting
PR Newswire
Result of Annual General Meeting
The Annual General Meeting of XP Power Limited was held at 401 Commonwealth Drive, Haw Par Technocentre, Lobby B, #02-02, Singapore 149598 on 20 April 2021, commencing at 5.00 p.m.Singapore time. All resolutions were unanimously passed by a show of hands.
For information, the following table shows the total votes cast by proxy voting on the resolutions that were put to the meeting. The total number of shares in issue was 19,642,296.
Resolution number
12,850,153
12,875,153
11,656,814
12,875,153
12,843,717
12,850,153
Enquiries:
Johan Olivier, Acting Chief Financial Officer +44 (0)118 984 5515
XP POWER-Aktie komplett kostenlos handeln - auf Smartbroker.de
Targeted News Service targetednews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from targetednews.com Daily Mail and Mail on Sunday newspapers.
XP POWER LTD - Annual Results for the year ended 31 December 2020
PR Newswire
Annual Results for the year ended 31 December 2020
XP Power, one of the world s leading developers and manufacturers of critical power control solutions for the Industrial Technology, Healthcare and Semiconductor Manufacturing Equipment sectors, announces its annual results for the year ended 31 December 2020.
2020
1
1
For details on adjusted measures refer to note 4 and note 5 of the consolidated financial statements.
Strong growth in order intake and revenue driven by the recovery in the Semiconductor Manufacturing Equipment sector and demand from our Healthcare customers as they increased supply of critical care devices for the treatment of COVID-19, offsetting weakness in Industrial Technology sector.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Valneva Reports FY 2020 Results and Major Corporate Achievements
VALNEVAFebruary 25, 2021 GMT
Excellent progress on clinical programs
Unprecedented partnering deal signed with Pfizer for Lyme disease vaccine candidate VLA15, including $130 million upfront payment as part of over $300 million for upfront and milestone payments
Positive initial Phase 2 results
Acceleration of pediatric development announced
Acceleration of chikungunya vaccine candidate VLA1553 into Phase 3
Only Phase 3 chikungunya vaccine program to date worldwide
Potentially eligible for Priority Review Voucher (PRV)1 - for first company to receive Biologics License Application (BLA) approval